ENVERIC BIOSCIENCES, INC. Amortization of Intangible Assets
ENVERIC BIOSCIENCES, INC. (ENVB) reported Amortization of Intangible Assets of $42.18 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-14
- ENVERIC BIOSCIENCES, INC. amortization of intangible assets for the quarter ending 2025-12-31 was $2.00, a 100.00% decline year-over-year.
- ENVERIC BIOSCIENCES, INC. amortization of intangible assets for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- ENVERIC BIOSCIENCES, INC. amortization of intangible assets for the quarter ending 2025-06-30 was -$2.00, a 100.00% decline year-over-year.
- ENVERIC BIOSCIENCES, INC. amortization of intangible assets for the quarter ending 2025-03-31 was $42.18K, a 0.01% decline year-over-year.
- ENVERIC BIOSCIENCES, INC. amortization of intangible assets for fiscal 2025 was $42.18K, a 75.00% decline from fiscal 2024.
- ENVERIC BIOSCIENCES, INC. amortization of intangible assets for fiscal 2024 was $168.75K, a 0.00% decline from fiscal 2023.
- ENVERIC BIOSCIENCES, INC. amortization of intangible assets for fiscal 2023 was $168.75K, a 0.00% increase from fiscal 2022.
- ENVERIC BIOSCIENCES, INC. amortization of intangible assets for fiscal 2022 was $168.75K, a 73.77% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $2.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $2.00 derived: sum of 2 quarters · filed 2026-03-27 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $42.18K 10-K · filed 2026-03-27 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$2.00 derived: sum of 2 quarters · filed 2026-08-14 | $42.18K 10-Q · filed 2025-11-14 | $84.37K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | -$2.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $42.18K 10-Q · filed 2026-08-14 | $84.37K derived: sum of 3 quarters · filed 2026-08-14 | $126.55K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $42.18K 10-Q · filed 2026-05-15 | $84.37K derived: sum of 2 quarters · filed 2026-05-15 | $126.56K derived: sum of 3 quarters · filed 2026-05-15 | $168.74K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $42.19K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $84.37K derived: sum of 2 quarters · filed 2026-03-27 | $126.56K derived: sum of 3 quarters · filed 2026-03-27 | $168.75K 10-K · filed 2026-03-27 | ||||
| 2024-09-30 | $42.19K 10-Q · filed 2024-11-14 | $84.38K derived: sum of 2 quarters · filed 2024-11-14 | $126.56K 10-Q · filed 2025-11-14 | $168.75K derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2024-06-30 | $42.19K 10-Q · filed 2024-08-12 | $84.38K 10-Q · filed 2025-08-14 | $126.56K derived: sum of 3 quarters · filed 2025-05-14 | $168.75K derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2024-03-31 | $42.19K 10-Q · filed 2025-05-14 | $84.38K derived: sum of 2 quarters · filed 2025-05-14 | $126.57K derived: sum of 3 quarters · filed 2025-05-14 | $168.75K derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $42.19K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $84.38K derived: sum of 2 quarters · filed 2025-03-28 | $126.57K derived: sum of 3 quarters · filed 2025-03-28 | $168.75K 10-K · filed 2025-03-28 | ||||
| 2023-09-30 | $42.19K 10-Q · filed 2024-11-14 | $84.38K derived: sum of 2 quarters · filed 2024-11-14 | $126.57K 10-Q · filed 2024-11-14 | $168.75K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $42.19K 10-Q · filed 2024-08-12 | $84.38K 10-Q · filed 2024-08-12 | $126.56K derived: sum of 3 quarters · filed 2024-08-12 | $168.75K derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $42.19K 10-Q · filed 2024-05-15 | $84.38K derived: sum of 2 quarters · filed 2024-05-15 | $126.57K derived: sum of 3 quarters · filed 2024-05-15 | $168.75K derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $42.19K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $84.38K derived: sum of 2 quarters · filed 2024-03-26 | $126.56K derived: sum of 3 quarters · filed 2024-03-26 | $168.75K 10-K · filed 2024-03-26 | ||||
| 2022-09-30 | $42.19K 10-Q · filed 2023-11-13 | $42.19K 10-Q · filed 2022-11-14 | $84.38K derived: sum of 2 quarters · filed 2023-11-13 | $126.56K 10-Q · filed 2023-11-13 | $287.78K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $42.19K 10-Q · filed 2023-08-11 | $84.38K 10-Q · filed 2023-08-11 | $245.59K derived: sum of 3 quarters · filed 2023-08-11 | $416.29K derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $42.19K 10-Q · filed 2023-05-15 | $203.41K derived: sum of 2 quarters · filed 2023-06-09 | $374.10K derived: sum of 3 quarters · filed 2023-06-09 | $548.12K derived: sum of 4 quarters · filed 2023-06-09 | ||||
| 2021-12-31 | $161.22K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-09 | $331.91K derived: sum of 2 quarters · filed 2023-06-09 | $505.93K derived: sum of 3 quarters · filed 2023-06-09 | $643.33K 10-K/A · filed 2023-06-09 | ||||
| 2021-09-30 | $170.69K 10-Q · filed 2022-11-14 | $344.71K derived: sum of 2 quarters · filed 2022-11-14 | $482.12K 10-Q · filed 2022-11-14 | $481.35K 10-Q · filed 2021-11-15 | $602.22K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $174.02K 10-Q · filed 2022-08-12 | $310.66K 10-Q · filed 2022-08-12 | $431.53K derived: sum of 3 quarters · filed 2022-08-12 | $431.53K derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $136.64K 10-Q · filed 2022-05-13 | $257.51K derived: sum of 2 quarters · filed 2022-05-13 | $257.51K derived: sum of 3 quarters · filed 2022-05-13 | $857.51K derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $120.87K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $120.87K derived: sum of 2 quarters · filed 2022-03-31 | $720.87K derived: sum of 3 quarters · filed 2022-03-31 | $120.87K 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $600.00K derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | $1.60M 10-Q · filed 2020-11-16 | $1.80M derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $1.10M 10-Q · filed 2020-08-14 | $1.80M derived: sum of 3 quarters · filed 2020-08-14 | $2.90M derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2020-03-31 | $500.00K 10-Q · filed 2020-05-15 | $1.20M derived: sum of 2 quarters · filed 2020-08-12 | $2.30M derived: sum of 3 quarters · filed 2020-11-16 | $2.20M derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-12-31 | $700.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-12 | $1.80M derived: sum of 2 quarters · filed 2020-11-16 | $1.70M derived: sum of 3 quarters · filed 2020-11-16 | $2.30M 10-K/A · filed 2020-08-12 | ||||
| 2019-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $1.00M derived: sum of 2 quarters · filed 2020-11-16 | $1.60M 10-Q · filed 2020-11-16 | $2.30M derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $500.00K 10-Q · filed 2019-08-14 | $1.20M derived: sum of 3 quarters · filed 2020-08-12 | $2.60M derived: sum of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | $600.00K 10-Q · filed 2020-05-15 | $1.30M derived: sum of 2 quarters · filed 2020-08-12 | $2.70M derived: sum of 3 quarters · filed 2020-08-12 | $2.70M derived: sum of 4 quarters · filed 2020-08-12 | ||||
| 2018-12-31 | $700.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-12 | $2.10M derived: sum of 2 quarters · filed 2020-08-12 | $2.10M derived: sum of 3 quarters · filed 2020-08-12 | $2.90M 10-K/A · filed 2020-08-12 | ||||
| 2018-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $1.40M derived: sum of 2 quarters · filed 2019-11-08 | $2.20M 10-Q · filed 2019-11-08 | $2.30M 10-Q · filed 2018-11-14 | $3.10M derived: sum of 4 quarters · filed 2019-11-08 | |||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $800.00K 10-Q · filed 2019-08-14 | $1.60M 10-Q · filed 2018-08-14 | $1.70M derived: sum of 3 quarters · filed 2019-08-14 | $2.50M derived: sum of 4 quarters · filed 2019-08-14 | |||
| 2018-03-31 | $800.00K 10-Q · filed 2019-05-14 | $1.70M derived: sum of 2 quarters · filed 2019-05-14 | $2.50M derived: sum of 3 quarters · filed 2019-05-14 | $3.30M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $1.70M derived: sum of 2 quarters · filed 2019-03-26 | $2.50M derived: sum of 3 quarters · filed 2019-03-26 | $3.20M 10-K · filed 2019-03-26 | $3.00M 10-K · filed 2018-04-02 | |||
| 2017-09-30 | $800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $1.60M derived: sum of 2 quarters · filed 2018-11-14 | $2.30M 10-Q · filed 2018-11-14 | $2.26M 10-Q · filed 2017-11-13 | ||||
| 2017-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $1.50M 10-Q · filed 2018-08-14 | $1.46M 10-Q · filed 2017-08-14 | |||||
| 2017-03-31 | $700.00K 10-Q · filed 2018-05-15 | $667.30K 10-Q · filed 2017-05-12 | ||||||
| 2016-12-31 | $1.40M 10-K · filed 2018-04-02 | $1.31M 10-K/A · filed 2017-04-04 | ||||||
| 2016-06-30 | $3.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $3.33M 10-Q · filed 2016-08-12 | $3.35M derived: sum of 3 quarters · filed 2016-08-12 | $3.35M derived: sum of 4 quarters · filed 2016-08-12 | ||||
| 2016-03-31 | $97.00K 10-Q · filed 2016-05-16 | $115.75K derived: sum of 2 quarters · filed 2016-05-16 | $115.75K derived: sum of 3 quarters · filed 2016-05-16 | $122.00K derived: sum of 4 quarters · filed 2016-05-16 | ||||
| 2015-12-31 | $18.75K derived: 10-KT 9 month − 10-Q 6 month · filed 2016-03-15 | $18.75K derived: sum of 2 quarters · filed 2016-03-15 | $25.00K 10-KT · filed 2016-03-15 | $164.75K 10-K/A · filed 2017-04-04 | ||||
| 2015-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-23 | $6.25K 10-Q · filed 2015-11-23 | $12.50K derived: sum of 3 quarters · filed 2016-05-16 | |||||
| 2015-06-30 | $6.25K 10-Q · filed 2015-08-18 | $164.75K 10-Q · filed 2016-08-12 | ||||||
| 2015-03-31 | $6.25K 10-Q · filed 2016-05-16 | $139.75K 10-KT · filed 2016-03-15 | ||||||
| 2014-06-30 | $6.25K 10-Q · filed 2015-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |